AngioDynamics ROCE 2024

AngioDynamics Aktienanalyse

What does AngioDynamics do?

AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling AngioDynamics's Return on Capital Employed (ROCE)

AngioDynamics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing AngioDynamics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

AngioDynamics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in AngioDynamics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about AngioDynamics stock

What is the ROCE (Return on Capital Employed) of AngioDynamics this year?

The ROCE of AngioDynamics is -0.06 undefined this year.

How has the ROCE (Return on Capital Employed) of AngioDynamics developed compared to the previous year?

The ROCE of AngioDynamics has increased by 20.84% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of AngioDynamics?

A high Return on Capital Employed (ROCE) indicates that AngioDynamics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of AngioDynamics?

A low ROCE (Return on Capital Employed) can indicate that AngioDynamics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from AngioDynamics impact the company?

An increase in the ROCE of AngioDynamics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of AngioDynamics affect the company?

A decrease in ROCE of AngioDynamics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of AngioDynamics?

Some factors that can affect AngioDynamics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of AngioDynamics so important for investors?

The ROCE of AngioDynamics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can AngioDynamics take to improve the ROCE?

To improve the ROCE, AngioDynamics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does AngioDynamics pay?

Over the past 12 months, AngioDynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AngioDynamics is expected to pay a dividend of 0 USD.

What is the dividend yield of AngioDynamics?

The current dividend yield of AngioDynamics is .

When does AngioDynamics pay dividends?

AngioDynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AngioDynamics?

AngioDynamics paid dividends every year for the past 0 years.

What is the dividend of AngioDynamics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AngioDynamics located?

AngioDynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von AngioDynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AngioDynamics from 7/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did AngioDynamics pay the last dividend?

The last dividend was paid out on 7/16/2024.

What was the dividend of AngioDynamics in the year 2023?

In the year 2023, AngioDynamics distributed 0 USD as dividends.

In which currency does AngioDynamics pay out the dividend?

The dividends of AngioDynamics are distributed in USD.